Related Experiment Video
Updated: Mar 3, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Parent-reported cognitive function is associated with leukoencephalopathy in children with brain tumors
Jin-Shei Lai1, Corey Bregman2, Frank Zelko3
1Medical Social Sciences and Pediatrics, Feinberg School of Medicine at Northwestern University, 633 N St Clair, #19-039, Chicago, IL, 60611, USA. js-lai@northwestern.edu.
The pediatric perceived cognitive function item bank (pedsPCF) effectively screens for cognitive dysfunction in children with brain tumors. This tool can identify cerebral compromise by correlating with MRI-based leukoencephalopathy grades, aiding early intervention.
Area of Science:
- Pediatric Neuro-oncology
- Neuropsychology
- Medical Imaging
Background:
- Cognitive dysfunction is a significant challenge for pediatric brain tumor patients.
- Early detection and intervention are crucial for improving outcomes.
- A user-friendly screening tool is needed to identify children requiring comprehensive neuropsychological assessment.
Purpose of the Study:
- To evaluate the pediatric perceived cognitive function item bank (pedsPCF) as a valid indicator of cerebral compromise in children with brain tumors.
- To determine if pedsPCF scores correlate with structural brain changes, specifically leukoencephalopathy grades on MRI.
Main Methods:
- Data from 99 children with brain tumors and their parents were analyzed.
- Leukoencephalopathy grade was assessed using MRI, evaluating white matter damage and deep white matter volume loss (range 0-4).
- Parents completed the pedsPCF, with scores standardized to a US general population T-score metric (mean=50, SD=10).
Main Results:
- The pedsPCF scores significantly differentiated between patients with varying leukoencephalopathy grades (F=4.14, p=0.0084).
- Effect sizes for discrimination ranged from 0.09 (grade 0 vs. 1) to 1.22 (grade 0 vs. 3/4).
- The mean pedsPCF T-score was 48.3 (SD=8.3), indicating overall performance relative to the general population.
Conclusions:
- The pedsPCF demonstrates validity as an indicator of leukoencephalopathy in pediatric brain tumor patients.
- Findings support the use of pedsPCF as a brief, user-friendly screening tool for neurocognitive deficits.
- This tool can facilitate timely referrals for comprehensive neurocognitive evaluations and early intervention strategies.
More Related Videos
08:26Event-related Potentials During Target-response Tasks to Study Cognitive Processes of Upper Limb Use in Children with Unilateral Cerebral Palsy
Published on: January 11, 2016
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021